Thursday, March 27, 2025
News

IIT Kanpur develops revolutionary seagrass-based sponge to control bleeding in emergencies

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Kanpur (Uttar Pradesh) | March 24, 2025 11:13:15 PM IST
Researchers at the Indian Institute of Technology Kanpur's Department of Materials Science and Engineering (MSE) achieved a breakthrough in emergency medical care with the development of a haemostatic sponge made from seagrass and cellulose.

Designed to stop bleeding within one minute of application, this innovation has the potential to transform emergency care in critical situations such as road accidents and traumatic injuries.

The sponge is crafted using red seagrass, abundantly found along India's coastlines, and has undergone rigorous testing, confirming its rapid clotting capability.

With three patents under its name, one with DRDO and two with IIT Kanpur as the sole inventor, the sponge's efficiency and accessibility position it as an indispensable tool for emergency responders.

Professor Vivek Verma of the Department of Materials Science and Engineering, IIT Kanpur, explained, "This haemostatic sponge is the result of combining India's natural resources with cutting-edge materials science. By using seagrass-derived agar and cellulose, we've developed a biodegradable, cost-effective solution that can save lives while supporting sustainable healthcare practices. It represents a significant step forward in improving emergency care, especially in areas where access to medical facilities is limited."

Inspired by the moisture-absorbing properties of traditional sponges, this innovation accelerates clotting by absorbing moisture from the injury site, reducing clotting time from eight minutes to one. Lightweight and easy to store, it is ideal for first-aid kits in emergencies like road accidents, military operations, or situations with limited immediate medical attention.

This innovation highlights IIT Kanpur's commitment to creating affordable, locally sourced healthcare solutions that address India's unique challenges. Human trials are slated to begin soon, with hopes to bring this pioneering product to market soon.

With the potential to significantly impact emergency healthcare, this innovative product is set to improve survival rates in critical situations and make life-saving solutions more accessible nationwide. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
'This is a dictatorship': Ajay Kumar Lal...
'This kind of comedy cannot happen in Ma...
Jagdeep Dhankhar pitches for NJAC, meets...
TRAI responds to DoT's back-reference in...
'Our CM has said action will be taken as...
New GBP Hospital block to be completed b...
More...    
 
 Top Stories
K&A: Unleashing the power of st... 
Congess gives privilege notice agai... 
HYLENR and TakeMe2Space to test LEN... 
J-K: DGP Nalin Prabhat joins combin... 
HSBC becomes official partner of Ar... 
Wipro's MyWiproVerse Chennai Transf... 
Court rejects BJP MP Raju Bista's d... 
Anahat, Chinappa, Akansha and Veer ...